London researchers are working with teams internationally to develop a non-invasive way to diagnose heart disease.
 
After extensive tests on dogs, researchers at Lawson Health Research Institute — the research arm of London’s hospitals – are getting ready to bring the new MRI-based diagnostic technique to human patients.

The U.S. Food and Drug Administration today allowed marketing of a new device, ClearMate, intended to be used in an emergency room setting to help treat patients suffering from carbon monoxide poisoning. The device uses a novel method for quickly removing carbon monoxide from the body by increasing a patient’s rate of breathing.